Abstract
Glucose-6-phosphate translocase enzyme, encoded by SLC37A4 gene, is a crucial enzyme involved in transporting glucose-6-phosphate into the endoplasmic reticulum. Inhibition of this enzyme can cause Von-Gierke's/glycogen storage disease sub-type 1b. The current study dealt to elucidate the intermolecular interactions to assess the inhibitory activity of Chlorogenic acid (CGA) against SLC37A4 was assessed by molecular docking and dynamic simulation. The alpha folded model of SLC37A4 and CGA 3D structure were optimized using CHARMM force field, using energy minimization protocol in the Discovery Studio software. Glucose-6-phosphate (G6P) and CGA molecular docking, Molecular dynamics (MD) simulation, analysis of binding free energy of G6P-SLC37A4 and CGA-SLC37A4 complexes was performed for 100 ns using GROMACS, followed by principal component analysis (PCA). The docking score of the CGA-SLC37A4 complex exhibited a higher docking score (– 8.2 kcal/mol) when compared to the G6P-SLC37A4 complex (– 6.5 kcal/mol), suggesting a stronger binding interaction between CGA and SLC37A4. Further, the MD simulation demonstrated a stable backbone and complex Root Mean Square Deviation (RMSD), the least RMS fluctuation, and stable active site residue interactions throughout the 100 ns production run. The CGA complex with SLC37A4 exhibits higher compactness and formed 8 hydrogen bonds to achieve stability. The binding free energy of the G6P-SLC37A4 and CGA-SLC37A4 complex was found to be – 12.73 and – 31.493 kcal/mol. Lys29 formed stable contact for both G6P (– 4.73 kJ/mol) and SLC37A4 (– 2.18 kJ/mol). This study imparts structural insights into the competitive inhibition of SLC37A4 by CGA. CGA shows potential as a candidate to induce manifestations of GSD1b by inhibiting glycogenolysis, and gluconeogenesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data supporting the findings of this study are available within the article and supplementary files.
References
Amadei A, Linssen ABM, Berendsen HJ (1993) Essential dynamics of proteins. Proteins 17(4):412–425. https://doi.org/10.1002/prot.340170408
Amadei A, Linssen AB, De GBL, Van Aalten DM, Berendsen HJ (1996) An efficient method for sampling the essential subspace of proteins. J Biomol Struct Dyn 13(4):615–625. https://doi.org/10.1080/07391102.1996.10508874
Arion WJ et al (1997) Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339(2):315–322
Arion WJ et al (1998) Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems. Arch Biochem Biophys. https://doi.org/10.1006/abbi.1997.0563
Bennett K, Burchell A (2013) Von Gierke disease. Brenner’s encyclopedia of genetics, 2nd edn. Elsevier, NY, pp 304–307. https://doi.org/10.1016/B978-0-12-374984-0.01631-4
Bhandare VV, Ramaswamy A (2018) The proteinopathy of D169G and K263E mutants at the RNA recognition motif (rrm) domain of tar DNA-binding protein (tdp43) causing neurological disorders: a computational study. J Biomol Struct Dyn 36(4):1075–1093. https://doi.org/10.1080/07391102.2017.1310670
Calderwood S et al (2001) Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97(2):376–382. https://doi.org/10.1182/blood.V97.2.376
Chou JY, Jun HS, Mansfield BC (2015) Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J Inherit Metab Dis 38(3):511–519. https://doi.org/10.1007/s10545-014-9772-x
Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511–1519. https://doi.org/10.1002/pro.5560020916
DasNandy A, Patil VS, Hegde HV, Harish DR, Roy S (2022) Elucidating type 2 diabetes mellitus risk factor by promoting lipid metabolism with gymnemagenin: an in vitro and in silico approach. Front Pharmacol. https://doi.org/10.3389/fphar.2022.1074342
Dieckgraefe BK, Korzenik ÆJR (2002) Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr 161:S88–S92. https://doi.org/10.1007/s00431-002-1011-z
Du X et al (2016) Insights into protein–ligand interactions: mechanisms, models, and methods. Int J Mol Sci 17(2):1–34. https://doi.org/10.3390/ijms17020144
Dwivedi PSR et al (2022) System biology-based investigation of Silymarin to trace hepatoprotective effect. Comput Biol Med 142:105223. https://doi.org/10.1016/j.compbiomed.2022.105223
Franco LM et al (2005) Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 28(2):153–162. https://doi.org/10.1007/s10545-005-7500-2
Hemmerle H et al (1997) Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med Chem 40(2):137–45
Hiraiwa H et al (1999) Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem 274(9):5532–5536. https://doi.org/10.1074/jbc.274.9.5532
Jumper J et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596(7873):583–589. https://doi.org/10.1038/s41586-021-03819-2
Khanal P, Patil VS, Bhandare VV, Dwivedi PS, Shastry CS, Patil BM et al (2022) Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds. Comput Biol Med. https://doi.org/10.1016/j.compbiomed.2022.105668
Khanal P, Patil VS, Bhandare VV, Patil PP, Patil BM, Dwivedi PS, Bhattacharya K, Harish DR, Roy S (2023) Systems and in vitro pharmacology profiling of diosgenin against breast cancer. Front Pharmacol 13:1052849. https://doi.org/10.3389/fphar.2022.1052849
Krivák R, Hoksza D (2018) P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. J Cheminformatics 10(1):1–12. https://doi.org/10.1186/s13321-018-0285-8
Kumari R, Kumar R, Lynn A (2014) G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54(7):1951–1962. https://doi.org/10.1021/ci500020m
Laskowski RA et al (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26(2):283–291. https://doi.org/10.1107/s0021889892009944
Leuzzi R et al (2003) Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 101(6):2381–2387. https://doi.org/10.1182/blood-2002-08-2576
Oguz MM et al (2015) Glycogen storage disease type 1B: An early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient. Genetic Couns 25(4):389–394
Ong KW, Hsu A, Tan BKH (2013) Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol 85(9):1341–1351. https://doi.org/10.1016/j.bcp.2013.02.008
Özen H (2007) ‘Glycogen storage diseases: new perspectives. World J Gastroenterol 13(18):2541–2553
Parikh NS, Ahlawat R (2021) Glycogen storage disease type I, StatPearls. Available at: https://www.ncbi.nlm.nih.gov/books/NBK534196/. Accessed 9 Oct 2022
Patil VS, Deshpande SH, Harish DR, Patil AS, Virge R, Nandy S, Roy S (2020) Gene set enrichment analysis, network pharmacology and in silico docking approach to understand the molecular mechanism of traditional medicines for the treatment of diabetes mellitus. J Proteins Proteom 11:297–310
Patil VS, Harish DR, Vetrivel U, Deshpande SH, Khanal P, Hegde HV et al (2022) Pharmacoinformatics analysis reveals flavonoids and diterpenoids from Andrographis paniculata and Thespesia populnea to target hepatocellular carcinoma induced by hepatitis B virus. Appl Sci 12(21):10691
Rake J et al (2002) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161:S20–S34. https://doi.org/10.1007/s00431-002-0999-4
Samdani A, Vetrivel U (2018) POAP: a GNU parallel based multithreaded pipeline of open babel and AutoDock suite for boosted high throughput virtual screening. Comput Biol Chem 74:39–48. https://doi.org/10.1016/j.compbiolchem.2018.02.012
Van Aalten DMF, Findlay JBC, Amadei A, Berendsen HJC (1995) Essential dynamics of the cellular retinol-binding protein evidence for ligand-induced conformational changes. Protein Eng 8(11):1129–1135. https://doi.org/10.1093/protein/8.11.1129
Van Der Spoel D et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701–1718. https://doi.org/10.1002/jcc.20291
Veiga-da-Cunha M et al (2019) Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci USA 116(4):1241–1250. https://doi.org/10.1073/pnas.1816143116
Yennamalli RM (2018) Protein design. Encycl Bioinform Comput Biol: ABC Bioinform 1–3(1):644–651. https://doi.org/10.1016/B978-0-12-809633-8.20151-9
Acknowledgements
Authors would like to express the help provided by the Principal of the Institution in carrying out the present work.
Funding
No funding was received from any funding institute for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All authors approved the manuscript for publication.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 20736 KB)
Supplementary file3 (MP4 15738 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Patil, S.B., Gadad, P.C. Elucidation of intermolecular interactions between chlorogenic acid and glucose-6-phosphate translocase: A step towards chemically induced glycogen storage disease type 1b model. 3 Biotech 13, 250 (2023). https://doi.org/10.1007/s13205-023-03661-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-023-03661-5